Publications

Lei JT, Mazumdar, TM, M Martinez-Moczygemba:  Three lysine residues in the common beta chain of the IL-5 receptor are required for Janus kinase-dependent receptor ubiquitination, endocytosis and signaling.  J Biol Chem. 2011 Sep 30. (Epub ahead of print).

Lee, M-S., Cherla, R.P., Jenson, M.H., Leyve-Illades, D., Martinez-Moczygemba, M., and Tesh, V.L: Shiga    toxins induce autophagy leading to differential signaling pathways in the toxin-sensitive and toxin-resistant human cells. Cell Microbiol 13(10):1479-1496, 2011.  PMID:21722286.

Martinez-Moczygemba, M, Doan, ML, Elidemir, O, Fan, LL, Cheung, SW, Lei, JT, Moore, JP, Tavana, G, Lewis, LR, Zhu, Y, Muzny, DM, Gibbs, RA, Huston, DP. 2008. “Pulmonary Alveolar Proteinosis Due to Deletion of the GM-CSFR? Gene in the X-Chromosome Pseudoautosomal Region 1.”  J Exp Med, 205(12):2711-6. Epub Oct 27, 2008

Lei, JT, Martinez-Moczygemba M. 2008. “Separate endocytic pathways regulate IL-5 Receptor Internalization and signaling.” J Leukoc Biol 84:499-509.

Martinez-Moczygemba M, DP Huston, Lei JT. 2007. “JAK kinases control IL-5 receptor ubiquitination, degradation and internalization.” J Leukoc Biol81(4):1137-48.

Martinez-Moczygemba M, DP Huston. 2003. “Biology of common ? receptor-signaling cytokines: IL-3, IL-5, and GM-CSF.” J Allergy Clin Immunol 112(4):653-665.

Huang JC, M Martinez-Moczygemba, AP Nguyen, DP Huston. 2003. “Modulating the interleukin-5 response in Asthma. In: Therapeutic Targets of Airway Inflammation.” Eds. NT Eissa and DP Huston; Marcel-Dekker, Inc., New York, New York. 177:495-518.

Foster PS, M Martinez-Moczygemba, DP Huston, DB Corry. 2002. “Interleukins 4, 5, and 13: emerging therapeutic targets in allergic disease.” Pharmacol Ther 94:253-264.

Martinez-Moczygemba M, DP Huston. 2001. “Proteasome regulation of ?c signaling reveals a novel mechanism for cytokine receptor heterotypic desensitization.” J Clin Invest 108:1797-1806.

Huston DP, MM Huston, RR Dickason, M Martinez-Moczygemba. 2000. “Interleukin-5, a therapeutic target in allergic inflammation.” Trans Am Clin Climatol Assoc 111:46-60.

Martinez-Moczygemba M, MJ Gutch, DL French, NC Reich. 1997. “Distinct STAT structure promotesinteraction of STAT2 with the p48 subunit of the interferon-a stimulated transcription factor, ISGF3.” J Biol Chem 272:20070-20076.

Kotanides H, M Martinez-Moczygemba, MF White, NC Reich. 1995. “Characterization of interleukin-4 nuclear activated factor/STAT and its activation independent of the insulin receptor substrate proteins.” J Biol Chem270:19481-19486.